MOTILIUM

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Spain, France, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug MOTILIUM contains one active pharmaceutical ingredient (API):

1 Domperidone UNII 5587267Z69 - DOMPERIDONE

Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary. Read about Domperidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MOTILIUM Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A03FA03	Domperidone	A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03F Propulsives → A03FA Propulsives
Discover more medicines within A03FA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1347X
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514502401135317, 514502403111318, 514502404118316, 514502405130311, 514502406137318, 514502407117310, 514512020024803
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01693376, 01693407, 02084550, 02334202, 02334219, 02739979, 03050843, 03050866
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.253-09-06
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 55410, 55411
Country: FR	Base de données publique des médicaments	Identifier(s): 63679194, 69742865
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 15659, 15662
Country: HK	Department of Health Drug Office	Identifier(s): 48305
Country: IE	Health Products Regulatory Authority	Identifier(s): 74284
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4332
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011620, 1011621, 1034132, 1068246, 1080373, 1087568, 1088479, 1090112
Country: MT	Medicines Authority	Identifier(s): AA521/02004, AA908/04804, MA1471/00501, PI908/04801A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 0041M79, 0042M79
Country: NG	Registered Drug Product Database	Identifier(s): 04-1293
Country: NL	Z-Index G-Standaard	Identifier(s): 12134171
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 6289
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3558
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W12227001, W12227002
Country: SG	Health Sciences Authority	Identifier(s): 02500P, 02891P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593095382, 8699593701054
Country: ZA	Health Products Regulatory Authority	Identifier(s): K/5.7.2/261, V/5.7.2/19